Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Clin Microbiol Infect ; 25(7): 851-856, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31203871

ABSTRACT

OBJECTIVES: Compliance with the World Health Organization 'how to handrub' action is suboptimal. Simplifying the hand-hygiene action may improve practice. However, it is crucial to preserve antibacterial efficacy. We tested the non-inferiority of 15 versus 30 seconds handrubbing for Staphylococcus aureus and Escherichia coli contamination at different loads, using hand-size customized alcohol-based handrub (ABHR) volumes. METHODS: In an EN1500-based study, 18 health-care workers (HCWs) with extensive experience in hand hygiene rubbed hands with a hand-size customized volume of isopropanol 60% v/v. They repeated the following sequence: hand contamination (E. coli or S. aureus; broth containing 108 or 106 CFU/mL); baseline fingertips sampling; handrubbing (15 or 30 seconds); re-sampling. The main outcome was log10 CFU corrected reduction factor (cRF) on HCWs' hands, applying a generalized linear mixed model with a random intercept for subject. RESULTS: The median cRF was 2.1 log10 (interquartile range 1.50-3.10). After fitting the model, cRF was significantly higher for S. aureus compared with E. coli but there was no significant effect for duration of handrubbing or contamination fluid concentration. Fifteen seconds of handrubbing was non-inferior to 30 (-0.06 log10, 95% CI -0.34 to 0.22; EN1500 0.60 log10 non-inferiority margin). This was confirmed in all pre-specified subgroups. CONCLUSION: Among experienced HCWs using a hand-size customized volume of ABHR, handrubbing for 15 seconds was non-inferior to 30 seconds in reducing bacterial load, irrespective of type of bacteria or contamination fluid concentration. This provides further support for a shorter, 15-seconds, hand-hygiene action.


Subject(s)
Bacterial Load , Disinfectants/administration & dosage , Escherichia coli/isolation & purification , Hand Disinfection/methods , Staphylococcus aureus/isolation & purification , Alcohols/administration & dosage , Cross-Over Studies , Female , Hand/microbiology , Humans , Male , Random Allocation , Time Factors
2.
J Hosp Infect ; 95(2): 189-193, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28081910

ABSTRACT

On the 10th anniversary of the 'Clean Care is Safer Care' programme, the World Health Organization (WHO) Collaborating Centre on Patient Safety launched the 'Global Hand Sanitizing Relay 2015' (HSRelay). This hospital-wide activity promotes the WHO handrubbing technique to improve hand hygiene (HH) compliance. More than 15,000 healthcare workers (HCWs) from 133 hospitals in 43 countries participated. Between May and September 2015, 14 hospitals submitted pre- and post-event HH compliance data; 57% (8/14) reported a significant increase while others showed minimal or no improvement (average absolute change 9.4%). The HSRelay demonstrated that HCWs were interested in novel strategies to improve HH compliance.


Subject(s)
Cross Infection/prevention & control , Guideline Adherence , Hand Hygiene/methods , Infection Control/methods , Humans , World Health Organization
3.
J Hosp Infect ; 93(2): 159-63, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26996091

ABSTRACT

BACKGROUND: When a child is hospitalized, parents have to share their role to protect the child with the hospital, and establish a partnership with healthcare workers to deliver safe care to the child, including undertaking good hand hygiene practices. AIM: To review the scientific evidence about the participation of parents in the promotion of hand hygiene in paediatric settings. METHODS: A systematic search of MEDLINE, EMBASE and SciELO databases was undertaken using the following terms: ('hand hygiene'[MeSH] OR 'hand hygiene' OR 'hand disinfection'[MeSH] OR hand disinf* OR hand wash* OR handwash* OR hand antisep*) AND (parent OR caregiver OR mother OR father OR family OR families OR relatives). The Integrated Quality Criteria for Review of Multiple Study Designs tool was used for quality assessment. FINDINGS: The literature search yielded 1645 articles, and 11 studies met the inclusion criteria for the final analysis. Most studies were observational, and were based on questionnaires or interviews. Most parents had little knowledge about the indications to perform hand hygiene, but recognized hand hygiene as a relevant tool for the prevention of healthcare-associated infections. Their willingness to remind healthcare workers about a failed opportunity to perform hand hygiene was variable and, overall, rather low. Parents felt more comfortable about reminding healthcare workers about hand hygiene if they had previously been invited to do so. CONCLUSIONS: Literature on the subject is scarce. The promotion of hand hygiene by parents should be further explored by research as a potential intervention for enhancing patient safety in paediatric settings.


Subject(s)
Hand Hygiene/methods , Health Education/methods , Infection Control/methods , Parents , Humans
4.
Braz. j. med. biol. res ; 48(8): 759-764, 08/2015. tab, graf
Article in English | LILACS | ID: lil-753059

ABSTRACT

Resistance to Mycobacterium tuberculosis is a reality worldwide, and its diagnosis continues to be difficult and time consuming. To face this challenge, the World Health Organization has recommended the use of rapid molecular tests. We evaluated the routine use (once a week) of a line probe assay (Genotype MTBDRplus) for early diagnosis of resistance and for assessment of the main related risk factors over 2 years. A total of 170 samples were tested: 15 (8.8%) were resistant, and multidrug resistance was detected in 10 (5.9%). The sensitivity profile took 3 weeks (2 weeks for culture and 1 week for rapid testing). Previous treatment for tuberculosis and the persistence of positive acid-fast smears after 4 months of supervised treatment were the major risk factors observed. The use of molecular tests enabled early diagnosis of drug-resistant bacilli and led to appropriate treatment of the disease. This information has the potential to interrupt the transmission chain of resistant M. tuberculosis.


Subject(s)
Humans , Male , Female , Adult , DNA, Bacterial/genetics , Genotyping Techniques/methods , Mycobacterium tuberculosis/genetics , Tuberculosis, Multidrug-Resistant/diagnosis , Antitubercular Agents/pharmacology , Bacteriological Techniques/methods , Brazil , Early Diagnosis , Isoniazid/pharmacology , Microbial Sensitivity Tests , Mycobacterium tuberculosis/drug effects , Rifampin/pharmacology , Risk Factors , Sensitivity and Specificity , Tuberculosis, Multidrug-Resistant/microbiology
5.
Braz J Med Biol Res ; 48(8): 759-64, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26132094

ABSTRACT

Resistance to Mycobacterium tuberculosis is a reality worldwide, and its diagnosis continues to be difficult and time consuming. To face this challenge, the World Health Organization has recommended the use of rapid molecular tests. We evaluated the routine use (once a week) of a line probe assay (Genotype MTBDRplus) for early diagnosis of resistance and for assessment of the main related risk factors over 2 years. A total of 170 samples were tested: 15 (8.8%) were resistant, and multidrug resistance was detected in 10 (5.9%). The sensitivity profile took 3 weeks (2 weeks for culture and 1 week for rapid testing). Previous treatment for tuberculosis and the persistence of positive acid-fast smears after 4 months of supervised treatment were the major risk factors observed. The use of molecular tests enabled early diagnosis of drug-resistant bacilli and led to appropriate treatment of the disease. This information has the potential to interrupt the transmission chain of resistant M. tuberculosis.


Subject(s)
DNA, Bacterial/genetics , Genotyping Techniques/methods , Mycobacterium tuberculosis/genetics , Tuberculosis, Multidrug-Resistant/diagnosis , Adult , Antitubercular Agents/pharmacology , Bacteriological Techniques/methods , Brazil , Early Diagnosis , Female , Humans , Isoniazid/pharmacology , Male , Microbial Sensitivity Tests , Mycobacterium tuberculosis/drug effects , Rifampin/pharmacology , Risk Factors , Sensitivity and Specificity , Tuberculosis, Multidrug-Resistant/microbiology
6.
Braz. j. med. biol. res ; 45(12): 1295-1300, Dec. 2012. tab
Article in English | LILACS | ID: lil-659654

ABSTRACT

Ventilator-associated pneumonia (VAP) remains one of the major causes of infection in the intensive care unit (ICU) and is associated with the length of hospital stay, duration of mechanical ventilation, and use of broad-spectrum antibiotics. We compared the frequency of VAP 10 months prior to (pre-intervention group) and 13 months after (post-intervention group) initiation of the use of a heat and moisture exchanger (HME) filter. This is a study with prospective before-and-after design performed in the ICU in a tertiary university hospital. Three hundred and fourteen patients were admitted to the ICU under mechanical ventilation, 168 of whom were included in group HH (heated humidifier) and 146 in group HME. The frequency of VAP per 1000 ventilator-days was similar for both the HH and HME groups (18.7 vs 17.4, respectively; P = 0.97). Duration of mechanical ventilation (11 vs 12 days, respectively; P = 0.48) and length of ICU stay (11 vs 12 days, respectively; P = 0.39) did not differ between the HH and HME groups. The chance of developing VAP was higher in patients with a longer ICU stay and longer duration of mechanical ventilation. This finding was similar when adjusted for the use of HME. The use of HME in intensive care did not reduce the incidence of VAP, the duration of mechanical ventilation, or the length of stay in the ICU in the study population.


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Hot Temperature , Pneumonia, Ventilator-Associated/prevention & control , Respiration, Artificial/instrumentation , Critical Illness , Humidity , Intensive Care Units , Length of Stay , Prospective Studies , Pneumonia, Ventilator-Associated/etiology , Risk Factors , Respiration, Artificial/adverse effects
7.
Braz J Med Biol Res ; 45(12): 1295-300, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23044627

ABSTRACT

Ventilator-associated pneumonia (VAP) remains one of the major causes of infection in the intensive care unit (ICU) and is associated with the length of hospital stay, duration of mechanical ventilation, and use of broad-spectrum antibiotics. We compared the frequency of VAP 10 months prior to (pre-intervention group) and 13 months after (post-intervention group) initiation of the use of a heat and moisture exchanger (HME) filter. This is a study with prospective before-and-after design performed in the ICU in a tertiary university hospital. Three hundred and fourteen patients were admitted to the ICU under mechanical ventilation, 168 of whom were included in group HH (heated humidifier) and 146 in group HME. The frequency of VAP per 1000 ventilator-days was similar for both the HH and HME groups (18.7 vs 17.4, respectively; P = 0.97). Duration of mechanical ventilation (11 vs 12 days, respectively; P = 0.48) and length of ICU stay (11 vs 12 days, respectively; P = 0.39) did not differ between the HH and HME groups. The chance of developing VAP was higher in patients with a longer ICU stay and longer duration of mechanical ventilation. This finding was similar when adjusted for the use of HME. The use of HME in intensive care did not reduce the incidence of VAP, the duration of mechanical ventilation, or the length of stay in the ICU in the study population.


Subject(s)
Hot Temperature , Pneumonia, Ventilator-Associated/prevention & control , Respiration, Artificial/instrumentation , Adolescent , Adult , Aged , Aged, 80 and over , Critical Illness , Female , Humans , Humidity , Intensive Care Units , Length of Stay , Male , Middle Aged , Pneumonia, Ventilator-Associated/etiology , Prospective Studies , Respiration, Artificial/adverse effects , Risk Factors , Young Adult
8.
Braz. j. med. biol. res ; 45(2): 158-162, Feb. 2012. ilus, tab
Article in English | LILACS | ID: lil-614578

ABSTRACT

The objective of this study is to retrospectively report the results of interventions for controlling a vancomycin-resistant enterococcus (VRE) outbreak in a tertiary-care pediatric intensive care unit (PICU) of a University Hospital. After identification of the outbreak, interventions were made at the following levels: patient care, microbiological surveillance, and medical and nursing staff training. Data were collected from computer-based databases and from the electronic prescription system. Vancomycin use progressively increased after March 2008, peaking in August 2009. Five cases of VRE infection were identified, with 3 deaths. After the interventions, we noted a significant reduction in vancomycin prescription and use (75 percent reduction), and the last case of VRE infection was identified 4 months later. The survivors remained colonized until hospital discharge. After interventions there was a transient increase in PICU length-of-stay and mortality. Since then, the use of vancomycin has remained relatively constant and strict, no other cases of VRE infection or colonization have been identified and length-of-stay and mortality returned to baseline. In conclusion, we showed that a bundle intervention aiming at a strict control of vancomycin use and full compliance with the Hospital Infection Control Practices Advisory Committee guidelines, along with contact precautions and hand-hygiene promotion, can be effective in reducing vancomycin use and the emergence and spread of vancomycin-resistant bacteria in a tertiary-care PICU.


Subject(s)
Child , Female , Humans , Anti-Bacterial Agents/administration & dosage , Cross Infection/prevention & control , Enterococcus/drug effects , Gram-Positive Bacterial Infections/prevention & control , Infection Control/methods , Vancomycin Resistance , Vancomycin/administration & dosage , Cross Infection/epidemiology , Cross Infection/microbiology , Disease Outbreaks , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/microbiology , Hospitals, University , Intensive Care Units, Pediatric , Program Evaluation , Retrospective Studies
9.
Braz J Med Biol Res ; 45(2): 158-62, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22267005

ABSTRACT

The objective of this study is to retrospectively report the results of interventions for controlling a vancomycin-resistant enterococcus (VRE) outbreak in a tertiary-care pediatric intensive care unit (PICU) of a University Hospital. After identification of the outbreak, interventions were made at the following levels: patient care, microbiological surveillance, and medical and nursing staff training. Data were collected from computer-based databases and from the electronic prescription system. Vancomycin use progressively increased after March 2008, peaking in August 2009. Five cases of VRE infection were identified, with 3 deaths. After the interventions, we noted a significant reduction in vancomycin prescription and use (75% reduction), and the last case of VRE infection was identified 4 months later. The survivors remained colonized until hospital discharge. After interventions there was a transient increase in PICU length-of-stay and mortality. Since then, the use of vancomycin has remained relatively constant and strict, no other cases of VRE infection or colonization have been identified and length-of-stay and mortality returned to baseline. In conclusion, we showed that a bundle intervention aiming at a strict control of vancomycin use and full compliance with the Hospital Infection Control Practices Advisory Committee guidelines, along with contact precautions and hand-hygiene promotion, can be effective in reducing vancomycin use and the emergence and spread of vancomycin-resistant bacteria in a tertiary-care PICU.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Cross Infection/prevention & control , Enterococcus/drug effects , Gram-Positive Bacterial Infections/prevention & control , Infection Control/methods , Vancomycin Resistance , Vancomycin/administration & dosage , Child , Cross Infection/epidemiology , Cross Infection/microbiology , Disease Outbreaks , Female , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/microbiology , Hospitals, University , Humans , Intensive Care Units, Pediatric , Male , Program Evaluation , Retrospective Studies
10.
Braz. j. med. biol. res ; 43(8): 794-798, Aug. 2010. ilus
Article in English | LILACS | ID: lil-554958

ABSTRACT

Zygomycosis is an infection caused by opportunistic fungi of the Zygomycetes class, specifically those from the Mucorales and Entomophthorales orders. It is an uncommon disease, mainly restricted to immunocompromised patients. We report a case of a 73-year-old male patient with a history of fever (39°C) lasting for 1 day, accompanied by shivering, trembling, and intense asthenia. The patient was admitted to the intensive care unit with complex partial seizures, and submitted to orotracheal intubation and mechanical ventilation under sedation with midazolam. The electroencephalogram showed evidence of non-convulsive status epilepticus. There is no fast specific laboratory test that permits confirmation of invasive fungal disease. Unless the physician suspects this condition, the disease may progress rapidly while the patient is treated with broad-spectrum antibiotics. Differential diagnosis between fungal and bacterial infection is often difficult. The clinical presentation is sometimes atypical, and etiological investigation is not always successful. In the present case, the histopathological examination of the biopsy obtained from the right temporal lobe indicated the presence of irregular, round, thick-walled fungi forming papillae and elongated structures of irregular diameter, with no septa, indicative of zygomycete (Basidiobolus). Treatment with liposomal amphotericin B and fluconazole was initiated after diagnosis of meningoencephalitis by zygomycete, with a successful outcome.


Subject(s)
Aged , Humans , Male , Entomophthorales/isolation & purification , Meningoencephalitis/microbiology , Shock, Septic/microbiology , Zygomycosis/diagnosis , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Follow-Up Studies , Fluconazole/therapeutic use , Immunocompromised Host , Meningoencephalitis/diagnosis , Meningoencephalitis/drug therapy , Shock, Septic/diagnosis , Shock, Septic/drug therapy , Treatment Outcome , Zygomycosis/drug therapy
11.
Braz J Med Biol Res ; 43(8): 794-8, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20658096

ABSTRACT

Zygomycosis is an infection caused by opportunistic fungi of the Zygomycetes class, specifically those from the Mucorales and Entomophthorales orders. It is an uncommon disease, mainly restricted to immunocompromised patients. We report a case of a 73-year-old male patient with a history of fever (39 degrees C) lasting for 1 day, accompanied by shivering, trembling, and intense asthenia. The patient was admitted to the intensive care unit with complex partial seizures, and submitted to orotracheal intubation and mechanical ventilation under sedation with midazolam. The electroencephalogram showed evidence of non-convulsive status epilepticus. There is no fast specific laboratory test that permits confirmation of invasive fungal disease. Unless the physician suspects this condition, the disease may progress rapidly while the patient is treated with broad-spectrum antibiotics. Differential diagnosis between fungal and bacterial infection is often difficult. The clinical presentation is sometimes atypical, and etiological investigation is not always successful. In the present case, the histopathological examination of the biopsy obtained from the right temporal lobe indicated the presence of irregular, round, thick-walled fungi forming papillae and elongated structures of irregular diameter, with no septa, indicative of zygomycete (Basidiobolus). Treatment with liposomal amphotericin B and fluconazole was initiated after diagnosis of meningoencephalitis by zygomycete, with a successful outcome.


Subject(s)
Entomophthorales/isolation & purification , Meningoencephalitis/microbiology , Shock, Septic/microbiology , Zygomycosis/diagnosis , Aged , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Fluconazole/therapeutic use , Follow-Up Studies , Humans , Immunocompromised Host , Male , Meningoencephalitis/diagnosis , Meningoencephalitis/drug therapy , Shock, Septic/diagnosis , Shock, Septic/drug therapy , Treatment Outcome , Zygomycosis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...